DFT investigation of atazanavir as potential inhibitor for 2019-nCoV coronavirus M protease
Author:
Publisher
Elsevier BV
Subject
Inorganic Chemistry,Organic Chemistry,Spectroscopy,Analytical Chemistry
Reference30 articles.
1. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy;Deeks;AIDS,1999
2. Review of atazanavir: a novel HIV protease inhibitor;Fuster;Expert Opin. Pharmacother.,2005
3. BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agents;Robinson;Antimicrob. Agents Chemother.,2000
4. Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice;Cleijsen;J. Antimicrob. Chemother.,2007
5. Atazanavir: its role in HIV treatment;Wood;Expert. Rev. Anti. Infect. Ther.,2008
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Harnessing allosteric inhibition: prioritizing LIMK2 inhibitors for targeted cancer therapy through pharmacophore-based virtual screening and essential molecular dynamics;Journal of Biomolecular Structure and Dynamics;2023-12-08
2. Density Functional Theory Investigation, Bioactivity, Absorption, Distribution, Metabolism, and Excretion Properties, Docking and in Silico Analysis of New Effective Piperazine Derivatives against Alzheimer’s Disease;Russian Journal of Physical Chemistry B;2023-06
3. Microparticles of Sericin-Dextran Conjugate for Improving the Solubility of Antiviral Drug;Journal of Functional Biomaterials;2023-05-24
4. Efficacy and Safety of Atazanavir/Ritonavir versus Lopinavir/Ritonavir in Hospitalized COVID-19 Patients: A Randomized Clinical Trial;Iranian Red Crescent Medical Journal;2022-04-22
5. Potential Protein and Enzyme Targets for In‐silico Development and Repurposing of Drug Against Coronaviruses;ChemistrySelect;2021-12-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3